The UCSF Healthcare Technology Assessment Program (HTAP) is a multi-disciplinary, physician-directed program that is charged with improving patient care through the objective evaluation of new health care technologies at UCSF. The primary goal of the program is to facilitate the adoption and use of safe, efficacious, and cost-effective health care technologies to improve patient care by considering issues related to the safety, efficacy, financial impact, and fit with the programmatic needs and mission of the UCSF Medical Center.
In order to ensure a fair, equitable, and successful program, the HTAP includes members of all clinical departments at UCSF that are involved with decisions regarding the acquisition and use of new medical technologies. Each HTAP member has been recommended by their Department Chair and approved by the Chief Medical Officer and the Director of the HTA Program.
The HTAP Committee is chaired by Kevin J. Bozic, MD, MBA, Associate Professor in the Department of Orthopaedic Surgery. Kent Soo Hoo, PhD serves as the HTAP Director. Dr. Soo Hoo has vast experience in technology assessment methodology and his roles include identifying technologies for consideration by HTAP, assisting physician requestors with gathering the available clinical and economic data related to new technology requests, and synthesizing the data for presentation to the Committee.
In order to ensure a fair, equitable, and successful program, the HTAP includes members of all clinical departments at UCSF that are involved with decisions regarding the acquisition and use of new medical technologies. Each HTAP member has been recommended by their Department Chair and approved by the Chief Medical Officer and the Director of the HTA Program.
The HTAP Committee is chaired by Kevin J. Bozic, MD, MBA, Associate Professor in the Department of Orthopaedic Surgery. Kent Soo Hoo, PhD serves as the HTAP Director. Dr. Soo Hoo has vast experience in technology assessment methodology and his roles include identifying technologies for consideration by HTAP, assisting physician requestors with gathering the available clinical and economic data related to new technology requests, and synthesizing the data for presentation to the Committee.
The UCSF Healthcare Technology Assessment Program (HTAP) is a multi-disciplinary, physician-directed program that is charged with improving patient care through the objective evaluation of new health care technologies at UCSF. The primary goal of the program is to facilitate the adoption and use of safe, efficacious, and cost-effective health care technologies to improve patient care by considering issues related to the safety, efficacy, financial impact, and fit with the programmatic needs and mission of the UCSF Medical Center.
In order to ensure a fair, equitable, and successful program, the HTAP includes members of all clinical departments at UCSF that are involved with decisions regarding the acquisition and use of new medical technologies. Each HTAP member has been recommended by their Department Chair and approved by the Chief Medical Officer and the Director of the HTA Program.
The HTAP Committee is chaired by Kevin J. Bozic, MD, MBA, Associate Professor in the Department of Orthopaedic Surgery. Kent Soo Hoo, PhD serves as the HTAP Director. Dr. Soo Hoo has vast experience in technology assessment methodology and his roles include identifying technologies for consideration by HTAP, assisting physician requestors with gathering the available clinical and economic data related to new technology requests, and synthesizing the data for presentation to the Committee.
In order to ensure a fair, equitable, and successful program, the HTAP includes members of all clinical departments at UCSF that are involved with decisions regarding the acquisition and use of new medical technologies. Each HTAP member has been recommended by their Department Chair and approved by the Chief Medical Officer and the Director of the HTA Program.
The HTAP Committee is chaired by Kevin J. Bozic, MD, MBA, Associate Professor in the Department of Orthopaedic Surgery. Kent Soo Hoo, PhD serves as the HTAP Director. Dr. Soo Hoo has vast experience in technology assessment methodology and his roles include identifying technologies for consideration by HTAP, assisting physician requestors with gathering the available clinical and economic data related to new technology requests, and synthesizing the data for presentation to the Committee.